• -
12 Results
A stethoscope on American paper currency.
Comparing Prices and Price Transparency Among Top-Ranked Hospitals and Close Competitors
A regulation from the Centers for Medicare and Medicaid Services (CMS) required that, starting January 1, 2021, all U.S. hospitals publicly display the cash price as well as the minimum and maximum negotiated charge for 300 “shoppable services.”
Vivian Ho, Alan Beltran Lara, David Ruiz, Peter Cram, M.D., Marah Short May 12, 2022
Person blowing out vape smoke
Vaping: Clearing the Air
The authors examine recent trends in vaping, research on its effectiveness for smoking cessation, the role of industry marketing and policy responses to increased use.
Katharine Neill Harris, William Martin February 28, 2020
Marijuana bud next to a gavel
The Case For Marijuana Decriminalization
In recent years public opinion surveys have found that a consistent and increasing percentage of Texans support marijuana reform, but this support has not translated into policy change. The authors explain why it should.
Katharine Neill Harris, William Martin April 16, 2019
Marijuana bud next to a gavel
Marijuana as Medicine
By providing regulated and safe access to medical cannabis to people with demonstrated need, the Texas Legislature can provide justified relief, help reduce the opioid epidemic, and save Texas millions of dollars, write the authors.
William Martin, Katharine Neill Harris April 15, 2019
US Capitol
All the Presidents' Man
Lauded as “The Pastor to the Presidents,” the late evangelist Billy Graham met with or gave counsel to every sitting commander-in-chief from Truman to Trump. This report, drawn from the author's book "A Prophet with Honor: The Billy Graham Story" (William Morrow, 1991; updated edition, Zondervan, 2019), provides insight on their relationships.
William Martin February 11, 2019
RX Medicine
Rx for U.S. Drug Policy: A New Paradigm
The core strategies of the U.S. War on Drugs are eradication, interdiction and incarceration. After a 40-year and trillion-dollar effort, illicit drugs remain available to meet a remarkably stable demand. Drawing on decades of government-gathered and publicly available data, William Martin, director of the Drug Policy Program, and contributing expert Jerry Epstein contend that U.S. drug policy is premised on incorrect assumptions, aims at the wrong targets and can never succeed. But because these data run counter to a century of anti-drug propaganda, they play only a small role in public policy, mass-media presentation and popular perception. In this policy report, Martin and Epstein call for a reexamination of the data and sweeping revision of existing strategies. They urge formation of a politically independent national scientific commission, its members chosen by the National Academy of Sciences, in consultation with the NIH and the Department of Health and Human Services, to facilitate open examination and honest consideration of alternatives to current failed or flawed policies.
William Martin, Jerry Epstein June 30, 2015